Interpretation of WHO Guidelines on tuberculosis care and support

doi:10.19982/j.issn.1000-6621.20220409

Chinese Journal of Antituberculosis ›› 2022, Vol. 44 ›› Issue (12): 1249-1252.doi: 10.19982/j.issn.1000-6621.20220409

• Interpretation of Standards • Previous Articles Next Articles

Interpretation of WHO Guidelines on tuberculosis care and support

Liu Eryong¹, Meng Qinglin¹, Wang Qian², Wang Jing¹, Zhou Lin¹()

¹Department of Tuberculosis Patients Care, National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China
²General Office, National Center for Tuberculosis Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China

Received:2022-10-19 Online:2022-12-10 Published:2022-12-02
Contact: Zhou Lin E-mail:zhoulin@chinacdc.cn
Supported by:
Tuberculosis Prevention and Control Project Funded by the Central Government-Daily Operation of Tuberculosis Business(228711)

Abstract

Abstract:

In July 2022, the World Health Organization (WHO) published Guidelines on tuberculosis care and support. The patient centered care activities were introduced from various interventions such as social support, treatment management and digital health technology. Through the interpretation of the guideline, to introduce the contents to the readers and provide reference to patients’ care activities in China.

Key words: World Health Organization, Social support, Disease management, Guidebooks

CLC Number:

Liu Eryong, Meng Qinglin, Wang Qian, Wang Jing, Zhou Lin. Interpretation of WHO Guidelines on tuberculosis care and support[J]. Chinese Journal of Antituberculosis, 2022, 44(12): 1249-1252. doi: 10.19982/j.issn.1000-6621.20220409

References 7

[1]	World Care Council. The Patients’ Charter for tuberculosis care. Geneva: World Care Council, 2006.
[2]	Hopewell PC. Updating the international standards for tuberculosis care. Int J Tuberc Lung Dis, 2014, 18(3): 253. doi:10.5588/ijtld.14.0035. doi: 10.5588/ijtld.14.0035 pmid: 24670556
[3]	World Health Organization. The WHO consolidated guidelines on tuberculosis. Module 4: treatment. Tuberculosis care and support. Geneva: World Health Organization, 2022.
[4]	World Health Organization. The WHO operational handbook on tuberculosis. Module 4: treatment-tuberculosis care and support. Geneva: World Health Organization, 2022.
[5]	刘二勇, 陈明亭, 周林, 等. 开展患者关怀行动提升结核病防治综合服务质量. 中国防痨杂志, 2022, 44(5): 433-437. doi:10.19982/j.issn.1000-6621.20220022. doi: 10.19982/j.issn.1000-6621.20220022
[6]	中国疾病预防控制中心结核病预防控制中心. 中国结核病患者关怀手册. 北京: 人民卫生出版社, 2021.
[7]	王前, 王嘉, 刘二勇, 等. 《中国结核病患者关怀手册》专家解读. 中国防痨杂志, 2022, 44 (1): 49-53. doi:10.19982/j.issn.1000-6621.20210613. doi: 10.19982/j.issn.1000-6621.20210613

[1]	Ultrasound Professional Committee of Tuberculosis Branch of Chinese Medical Association, Interventional Ultrasound Professional Committee of Interventional Physician Branch of Chinese Medical Doctor Association Danwei. Expert consensus on ultrasound diagnosis, classification and interventional therapy of tuberculous pleurisy (2022 Edition) [J]. Chinese Journal of Antituberculosis, 2022, 44(9): 880-897.
[2]	Cheng Jun, Lu Wei. Interpretation of Guideline on tuberculosis infection prevention and control in primary health care institute [J]. Chinese Journal of Antituberculosis, 2022, 44(8): 762-767.
[3]	ZHANG Hui, ZHAO Yan-lin. Strengthen multi-sectoral cooperation mechanism to further promote the tuberculosis prevention and control in China [J]. Chinese Journal of Antituberculosis, 2022, 44(2): 115-119.
[4]	WANG Qian, WANG Jia, LIU Er-yong, CHEN Ming-ting, ZHOU Lin.. Expert interpretation of “Handbook of Care for Tuberculosis Patients in China” [J]. Chinese Journal of Antituberculosis, 2022, 44(1): 49-53.
[5]	Beijing Chest Hospital, Capital Medical University, Editorial Board of Chinese Journal of Antituberculosis. Expert consensus on the therapeutic drug monitoring of anti-tuberculosis drugs [J]. Chinese Journal of Antituberculosis, 2021, 43(9): 867-873.
[6]	. Guideline for clinical management of adverse reactions of bacillus Calmette-Guérin [J]. Chinese Journal of Antituberculosis, 2021, 43(6): 532-538.
[7]	CHEN Qiu-qi, DENG Guo-fang. Discussion on the comorbidities and management of tuberculosis in China [J]. Chinese Journal of Antituberculosis, 2021, 43(6): 546-549.
[8]	LI Xiang-wu, CHEN Wen-jie, ZHONG Qiu, CHENG Shi-ming, PENG Jian-ming, LIU Zhi-dong.. Impact of intervention measures for COVID-19 epidemic on tuberculosis prevention and control in Huizhou [J]. Chinese Journal of Antituberculosis, 2021, 43(10): 1052-1055.
[9]	National Clinical Research Center for Infectious Disease/, The Third People’s Hospital of Shenzhen, National Clinical Research Center for Metabolic Disease, The Second Xiangya Hospital of Central South University, Chinese Antituberculosis Association, Editorial Board of Chinese Journal of Antituberculosis. Expert consensus on treatment and management of tuberculosis-diabetes mellitus [J]. Chinese Journal of Antituberculosis, 2021, 43(1): 12-22.
[10]	LIU Xiao-li, LEI Li-mei, GUO Zhou-li, HUANG Yin, XU Jing, ZHAO Xia, WANG Yan, FU Li. Study on the relationship of stigma and social support of tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 1002-1008.
[11]	LI Tao, DU Xin, CHEN Wei, HUANG Fei, ZHAO Yan-lin, ZHANG Hui. Review and prospect of tuberculosis management information surveillance and monitoring in China [J]. Chinese Journal of Antituberculosis, 2020, 42(7): 657-661.
[12]	LI Xiao-kun, YUAN Yan-li, YANG Guang-xu, WU Yuan-yuan. Design and application of Tuberculosis Designated Hospital Information Management Platform in Changchun [J]. Chinese Journal of Antituberculosis, 2020, 42(7): 671-675.
[13]	LIU Guang-tian, LIU Tao, WANG Xiao-wei, LEI Juan, TIAN Xiao-mei, WANG Xiao-lin. Application of “Internet+Medical Treatment” model in tuberculosis prevention and treatment in Ningxia [J]. Chinese Journal of Antituberculosis, 2020, 42(7): 676-681.
[14]	TANG Ling-ling, CHEN Dan-ping, FANG Xue-e, SHI Ting, CAI Li-ping, LI Ce. Study on the influencing factors of perceived social support in patients with drug-resistant tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(6): 604-608.
[15]	WENG Jian-feng,PENG Jian-ming,LIU Zhi-dong,ZHAN Mei-quan,LI Xiao-fen,CHEN Wen-jie. Evaluation of effectiveness of applying Mobile integrated management system in school TB prevention and control [J]. Chinese Journal of Antituberculosis, 2020, 42(4): 335-338.

Interpretation of WHO Guidelines on tuberculosis care and support

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 7

Related Articles 15

Recommended Articles

Metrics

Comments